Q2 2026 delivered strong revenue and net income growth, with record net bookings and a robust business environment. Oncology bookings surged, cancellations declined, and guidance for 2026 was raised, reflecting confidence in continued momentum.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.